Results generated from a syngeneic breast cancer model have corroborated that inhibition of SK1 in tumor cells decreased S1P levels and lung and lymph nodes metastasis through the disruption of angiogenesis and lymphangiogenesis [24]. The gene discussed is MBTPS1; the disease is breast carcinoma.